TYPE2 DIABETES
Clinical trials for TYPE2 DIABETES explained in plain language.
Never miss a new study
Get alerted when new TYPE2 DIABETES trials appear
Sign up with your email to follow new studies for TYPE2 DIABETES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a diabetes pill steady blood sugar after bariatric surgery?
Disease control ENROLLING_BY_INVITATIONThis study tests whether the drug dapagliflozin can help control blood sugar levels in people who have had bariatric surgery, both those with and without type 2 diabetes. Researchers will use a continuous glucose monitor to track blood sugar highs and lows over time. The goal is …
Matched conditions: TYPE2 DIABETES
Phase: PHASE2 • Sponsor: Dasman Diabetes Institute • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Intensive diet and exercise may help control type 2 diabetes
Disease control OngoingThis study tests whether a 12-week program of either a very low-calorie diet or high-intensity exercise can improve blood sugar control in adults aged 40-70 who are newly diagnosed with type 2 diabetes and overweight. Participants are randomly assigned to one of these intensive l…
Matched conditions: TYPE2 DIABETES
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
Gene test reveals who gets more from diabetes pill
Knowledge-focused OngoingThis study looks at how the diabetes drug sitagliptin affects people who naturally have lower levels of a protein called DPP4 due to their genes. Researchers will compare blood sugar and other markers in 20 adults with and without this gene change. The goal is to understand why s…
Matched conditions: TYPE2 DIABETES
Phase: PHASE4 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 26, 2026 08:10 UTC
-
Massive diabetes drug showdown: which one protects your heart and kidneys best?
Knowledge-focused OngoingThis study looks at health records from over 780,000 people with type 2 diabetes to compare four common second-line drugs: SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas. The goal is to see which drug is safest and most effective at preventing hear…
Matched conditions: TYPE2 DIABETES
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC